Colleen Darnell, MD
Medical Oncologist
Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma
Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Targeted Therapy
University Hospital - University of Cincinnati College of Medicine
Residency
University Hospital - University of Cincinnati College of Medicine
Fellowship
Northeast Ohio Medical University
Medical School
American Board of Internal Medicine
American Board of Internal Medicine - Hematology
American Board of Internal Medicine - Oncology
OH State Medical License Active through 2017
KY State Medical License Active through 2018
A patient-derived somatic mutation in the epidermal growth factor receptor ligand-binding domain confers increased sensitivity to cetuximab in head and neck cancer.
Bahassi, E. M.,Li, Y. Q.,Wise-Draper, T. M.,Deng, L.,Wang, J.,Darnell, C. N.,Wilson, K. M.,Wells, S. I.,Stambrook, P. J.,Rixe, O.; Eur. J. Cancer. 2013 Jul.
See more >>Target inhibition in antiangiogenic therapy a wide spectrum of selectivity and specificity.
Kelly, R. J., Darnell, C., Rixe, O.; Cancer J. 2010 Nov 01.
See more >>